Syneron Medical completes agreement eo tner global joint venture in home beauty Syneron Medical announced that it has completed its previously announced agreement with Unilever Ventures to create a global joint venture in home beauty devices. The new joint venture, Iluminage Beauty, will develop and bring to consumers innovative, high performance beauty solutions, empowering them with professional level devices for at-home use.
News For ELOS From The Last 14 Days
Check below for free stories on ELOS the last two weeks.
Syneron Medical recommend following FDA clearance at Maxim Maxim recommends investors continue buying shares of Syneron Medical following the FDA clearance of UltraShape. Maxim says UltraShape expands the base of body shaping treatments that physicians may use with complimentary Syneron systems and it keeps a Buy rating on the stock with a $16 price target.